Lirilumab Biosimilar - Anti-KIR2DL2 Antibody - BSA and Azide free (A318836)

Lirilumab Biosimilar - Anti-KIR2DL2 Antibody - BSA and Azide free

Recombinant human monoclonal antibody to KIR2DL2.

Flow Cytometry: 1:100

Human

Human

Monoclonal

IgG4

Unconjugated

Affinity chromatography.

Reconstitution dependent.

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

CD158 antigen-like family member B1, CD158b, CD158b1, KI2L2_HUMAN, Killer cell immunoglobulin like receptor two domains long cytoplasmic tail 2, Killer cell immunoglobulin-like receptor 2DL2, MHC class I NK cell receptor, Natural killer-associated transcript 6, NKAT 6, NKAT-6, NKAT6, p58 natural killer cell receptor clone CL-43, p58 NK receptor CL-43, p58.2